ALT-2074 Uses, Dosage, Side Effects and more
An organoselenium drug previously studied by Oxis International in Phase-II clinical trials for ulcerative colitis patients. Some indications of efficacy were demonstrated. BXT-51072 has enthusiastic endorsement for treatment in cardiovascular indications, primarily because of its ability to mimic the function of glutathione peroxidase.
| Attribute | Details |
|---|---|
| Trade Name | ALT-2074 |
| Generic | ALT-2074 |
| Type | |
| Formula | C10H13NSe |
| Weight | Average: 226.18 Monoisotopic: 227.021321249 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in cardiovascular disorders and diabetes mellitus type 1 and 2.
Toxicity
IC50 2.0–2.6 μM.
Half Life
2.08 (+/-0.17) hours.
Clearance
24.15 (+/-2.38) (ml min-1kg-1).
